Abstract:Somatic genome editing in mouse models has increased our understanding of the in vivo effects of genetic alterations in areas ranging from neuroscience to cancer biology and beyond. However, existing models are limited in their ability to create multiple targeted edits. Thus, our understanding of the complex genetic interactions that underlie development, homeostasis, and disease remains incomplete. Cas12a is an RNA-guided endonuclease with unique attributes that enable simple targeting of multiple genes with crRNA arrays containing tandem guides. To accelerate and expand the generation of complex genotypes in somatic cells, we generated transgenic mice with Cre-regulated and constitutive expression of enhanced Acidaminococcus sp. Cas12a (enAsCas12a). In these mice, enAsCas12a-mediated somatic genome editing robustly generated compound genotypes, as exemplified by the initiation of diverse cancer types driven by homozygous inactivation of trios of tumor suppressor genes. We further integrated these modular crRNA arrays with clonal barcoding to quantify the size and number of tumors with each array, as well as the efficiency of each crRNA. These Cas12a alleles will enable the rapid generation of disease models and broadly facilitate the high-throughput investigation of coincident genomic alterations in somatic cells in vivo.

What problem does this paper attempt to address?

This paper aims to solve the problem of the limited ability of existing mouse models in generating complex genotypes. Specifically, existing models have difficulty creating multiple targeted edits, which limits our understanding of complex genetic interactions in development, homeostasis, and disease. By using Cas12a (an RNA - guided endonuclease) with unique properties, researchers have developed a new method that can perform multiplex gene editing in somatic cells more efficiently. This method not only accelerates the generation of complex genotypes but also makes it possible to conduct high - throughput studies of genomic alterations in somatic cells in vivo. ### Main problems: 1. **Limitations of existing models**: Current mouse models have limitations in creating multiple targeted gene edits, especially when generating complex genotypes, such as multiple gene mutations in cancer. 2. **Advantages of Cas12a**: Cas12a can target multiple genes simultaneously through a simple crRNA array without requiring each guide RNA to have its own promoter and tracrRNA, which greatly simplifies the cloning process. 3. **Requirement for generating complex genotypes**: In order to better understand the complexity of human cancer, it is necessary to be able to efficiently generate models containing multiple gene alterations in somatic cells. ### Solutions: - **Generating Cas12a transgenic mice**: Researchers have generated transgenic mice expressing enhanced AsCas12a (enAsCas12a), and these mice can regulate or constitutively express Cas12a through Cre recombinase. - **Efficient multiplex gene editing**: By using Cas12a - mediated somatic gene editing, researchers can quickly generate complex genotypes containing multiple gene alterations, for example, by simultaneously inactivating multiple tumor - suppressor genes to induce different types of cancer. - **Quantifying tumorigenesis**: In combination with clone - barcoding technology, researchers can quantify the efficiency of each crRNA and the size and number of each clonal tumor. ### Specific applications: - **Lung cancer model**: By inactivating three tumor - suppressor genes, Nf1, Rasa1, and Pten, lung adenocarcinoma was successfully induced. - **Small - cell lung cancer model**: By inactivating three genes, Rb1, Trp53, and Rbl2, small - cell lung cancer was successfully induced. - **Pancreatic cancer model**: By inactivating three genes, Trp53, Cdkn2a, and Smad4, pancreatic ductal adenocarcinoma (PDAC) was successfully induced. In summary, this paper provides an efficient method for generating complex genotypes by developing Cas12a transgenic mice, opening up new avenues for the modeling and research of cancer and other complex diseases.

Efficient and multiplexed somatic genome editing with Cas12a mice

Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening

High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogenetics

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice

Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors

Precision Cancer Mouse Models Through Genome Editing with CRISPR-Cas9.

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice

Enhanced Mammalian Genome Editing by New Cas12a Orthologs with Optimized Crrna Scaffolds

Improved Prime Editors Enable Pathogenic Allele Correction and Cancer Modelling in Adult Mice

Multiplexed Genome Regulation in Vivo with Hyper-Efficient Cas12a

In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer

A non-inheritable maternal Cas9-based multiple-gene editing system in mice

Multiplex Genome Engineering Using CRISPR/Cas Systems

Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes

Simultaneous zygotic inactivation of multiple genes in mouse through CRISPR/Cas9-mediated base editing

Fast, multiplexable and highly efficient somatic gene deletions in adult mouse skeletal muscle fibers using AAV-CRISPR/Cas9

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos